Teixeira DS, Louzeiro GC, Figueiredo MA, Cherubini K, Salum FG. Erythromycin: an alternative for the management of oral mucositis?. Med Oral Patol Oral Cir Bucal. 2022 Sep 1;27 (5):e452-9.
doi:10.4317/medoral.25439
https://dx.doi.org/doi:10.4317/medoral.25439
1.Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2018;68:394-424. |
PMid:30207593 |
2. Prado NS, Bonan RF, Leonel AC, Castro JF, Carvalho EJ, Silveira FM, et al. Awareness on oral cancer among patients attending dental school clinics in Brazil. Med Oral Patol Oral Cir Bucal. 2020;25:e89-95. |
PMid:31880286 |
3. Hassona Y, Scully C, Shahin A, Maayta W, Sawair F. Factors Influencing Early Detection of Oral Cancer by Primary Health-Care Professionals. J Cancer Educ. 2016;31:285-91. |
PMid:25851202 |
4. López-Jornet P, Camacho-Alonso F. The quality of internet sites providing information relating to oral cancer. Oral Oncol. 2009;45:95-8. |
PMid:19457707 |
5. Hassona Y, Taimeh D, Marahleh A, Scully C. YouTube as a source of information on mouth (oral) cancer. Oral Dis. 2016;22:202-8. |
PMid:26718020 |
6. Delli K, Livas C, Vissink A, Spijkervet FK. Is YouTube useful as a source of information for Sjögren's syndrome? Oral Dis. 2016;22:196-201. |
PMid:26602325 |
7. Jayaratne YS, Anderson NK, Zwahlen RA. Readability of websites containing information on dental implants. Clin Oral Implants Res. 2014;25:1319-24. |
PMid:24148074 |
8. Varela-Centelles P, Ledesma-Ludi Y, Seoane-Romero JM, Seoane J. Information about oral cancer on the Internet: our patients cannot understand it. Br J Oral Maxillofac Surg. 2015;53:393-5. |
PMid:25703184 |
9. Eysenbach G, Powell J, Kuss O, Sa ER. Empirical Studies Assessing the Quality of Health Information for Consumers: A Systematic Review. JAMA 2002;287:2691-700. |
PMid:12020305 |
10. Neiger BL, Thackery R, Burton SH, Giraud-Carrier CG, Fagen MC. Evaluating social media's capacity to develop engaged audiences in health promotion settings: Use of Twitter metrics as a case study. Health Promot Pract. 2013;14:157-62. |
PMid:23271716 |
11. Best J, Muzaffar J, Mitchell-Innes A. Quality of information available via the internet for patients with head and neck cancer: are we improving?. Eur Arch Otorhinolaryngol. 2014;272:3499-505. |
PMid:25370600 |
12. Vivien A, Kowalski V, Chatellier A, Babin E, Bénateau H, Veyssie A. Information quality in general public French-speaking websites dedicated to oral cancer detection. J Stomatol Oral Maxillofac Surg. 2017;118: 20-8. |
PMid:28330570 |
13. Silberg WM, Lundberg GD, Musacchio RA. Assessing, controlling, and assuring the quality of medical information on the Internet. JAMA. 1997;277:1244-5. |
PMid:9103351 |
14. Aguirre PEA, Coelho MM, Rios D, Machado MAAM, Cruvinel AFP, Cruvinel T. Evaluating the dental caries-related information on Brazilian Websites: qualitative study. J Med Internet Res. 2017;19:e415. |
PMid:29237585 PMCid:PMC5745348 |
15. Boyer C, Gaudinat A, Baujard V, Geissbühler A. Health on the net foundation: assessing the quality of health web pages all over the world. Stud Health Technol Inform. 2007;129:1017-21. |
PMid:17911869 |
16. Madathil KC, Rivera-rodriguez AJ, Greenstein JS, Gramopadhye AK. Healthcare information on YouTube: A systematic review. Health Informatics J. 2015;21:173-94. |
PMid:24670899 |
17. Bezerra NV, Leite KL, Medeiros MM, Martins ML, Cardoso AMR, Alves PM, et al. Impact of the anatomical location, alcoholism and smoking on the prevalence of advanced oral cancer in Brazil. Med Oral Patol Oral Cirug Bucal. 2018;23:e295-301. |
PMid:29680854 PMCid:PMC5945237 |
18. Dantas TS, de Barros Silva PG, Sousa EF, da Cunha MP, de Aguiar ASW, Costa FWG, et al. Influence of Educational Level, Stage, and Histological Type on Survival of Oral Cancer in a Brazilian Population: a retrospective study of 10 years observation. Medicine. 2016;95:1-10. |
PMid:26817864 PMCid:PMC4998238 |
19. López-Jornet P, Camacho-Alonso F. The quality of internet information relating to oral leukoplakia. Med Oral Patol Oral Cirug Bucal. 2010;15:727-31. |
PMid:20383096 |
20. Martins MAP, Costa JM, Mambrini JVM, Ribeiro ALP, Benjamin EJ, Brant LCC, et al. Health literacy and warfarin therapy at two anticoagulation clinics in Brazil. Heart. 2017;103:1089-95. |
PMid:28258243 PMCid:PMC5595143 |
21. Chang JS, Lo IH, Wong TY, Huang CC, Lee WT, Tsai ST, et al. Investigating the association between oral hygiene and head and neck cancer. Oral Oncol. 2013;49:1010-7. |
PMid:23948049 |
22. Manoharan S, Nagaraja V, Eslick GD. Ill-fitting dentures and oral cancer: a meta-analysis. Oral Oncol. 2014;50:1058-61. |
PMid:25169920 |
23. Scoccianti C, Cecchini M, Anderson AS, Berrino F, Boutron-Ruault M-C, Espina C, et al. European Code against Cancer 4th Edition: alcohol drinking and cancer. Cancer Epidemiol. 2016;45:181-8. |
PMid:27816465 |
24. Shewale JB, Gillison ML. Dynamic factors affecting HPV-attributable fraction for head and neck cancers. Curr Opin Virol. 2019;39:33-40. |
1. Campos MI, Campos CN, Aarestrup FM, Aarestrup BJ. Oral mucositis in cancer treatment: Natural history, prevention and treatment. Mol Clin Oncol. 2014;2:337-40. |
PMid:24772297 PMCid:PMC3999143 |
2. Villa A, Sonis ST. Mucositis: pathobiology and management. Curr Opin Oncol. 2015;27:159-64. |
PMid:25774860 |
3. Sonis ST. The pathobiology of mucositis. Nat Rev Cancer. 2004;4:277-84. |
PMid:15057287 |
4. Ren W, Li XH, Chen BD, Wooley PH. Erythromycin inhibits wear debris-induced osteoclastogenesis by modulation of murine macrophage NF-kappaB activity. J Orthop Res. 2004;22:21-9. |
PMid:14656655 |
5. Uchimura T, Nakamura DS, Link EM, Noguchi Y, Ōmura S, Sunazuka T, et al. Erythromycin acts through the ghrelin receptor to attenuate inflammatory responses in chondrocytes and maintain joint integrity. Biochem Pharmacol. 2019;165:79-90. |
PMid:30862504 PMCid:PMC7704045 |
6. Hirano E, Shimada K, Komiyama T, Fujita M, Kishimoto C. Erythromycin treatment suppresses myocardial injury in autoimmune myocarditis in rats via suppression of superoxide production. Int J Cardiol. 2013;167:2228-33. |
PMid:22727964 |
7. Desaki M, Takizawa H, Ohtoshi T, Kasama T, Kobayashi K, Sunazuka T, et al. Erythromycin suppresses nuclear factor-kappaB and activator protein-1 activation in human bronchial epithelial cells. Biochem Biophys Res Commun. 2000;267:124-8. |
PMid:10623585 |
8. Tsang KW, Ng P, Ho PL, Chan S, Tipoe G, Leung R, et al. Effects of erythromycin on Pseudomonas aeruginosa adherence to collagen and morphology in vitro. Eur Respir J. 2003;21:401-6. |
PMid:12661992 |
9. Teixeira DDS, de Figueiredo MAZ, Cherubini K, Garcia MCR, de Oliveira SD, Salum FG. Topical chlorhexidine, povidone-iodine and erythromycin in the repair of traumatic ulcers on the rat tongue: Clinical, histological and microbiological evaluation. Arch Oral Biol. 2018;87:218-25. |
PMid:29316457 |
10. Lalla RV, Bowen J, Barasch A, Elting L, Epstein J, Keefe DM, et al. Mucositis Guidelines Leadership Group of the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO). MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer. 2014;120:1453-61. |
PMid:24615748 PMCid:PMC4164022 |
11. Valeh M, Kargar M, Mansouri A, Kamranzadeh H, Gholami K, Heidari K, et al. Factors Affecting the Incidence and Severity of Oral Mucositis Following Hematopoietic Stem Cell Transplantation. Int J Hematol Oncol Stem Cell Res. 2018;12:142-52. |
PMid:30233777 |
12. Al Ibraheemi AA, Shamoun S. Incidence and Risk Factors of Oral Mucositis in Patients with Breast Cancer Who Receiving Chemotherapy in Al-Bashir Hospital. Int J Hematol Oncol Stem Cell Res. 2016;10:217-23. |
PMid:27928476 |
13. Sonis ST, Eilers JP, Epstein JB, LeVeque FG, Liggett WH Jr, Mulagha MT, et al. Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy. Mucositis Study Group. Cancer. 1999;85:2103-13. |
https://doi.org/10.1002/(SICI)1097-0142(19990515)85:10<2103::AID-CNCR2>3.0.CO;2-0 |
PMid:10326686 |
14. Hickman M, Meade SJ, Fong C, Sanghera P, Good J, Hartley A. A prospective comparison of common toxicity criteria adverse events Version 3 and 4 in assessing oral mucositis for oral and oropharyngeal carcinoma. Tech Innov Patient Support Radiat Oncol. 2017;1:18-21. |
PMid:32095539 PMCid:PMC7033787 |
15. López-Castaño F, Oñate-Sánchez RE, Roldán-Chicano R, Cabrerizo-Merino MC. Measurement of secondary mucositis to oncohematologic treatment by means of different scale. Review. Med Oral Patol Oral Cir Bucal. 2005;10:412-21. |
PMid:16264377 |
16. Elting LS, Shih YC, Stiff PJ, Bensinger W, Cantor SB, Cooksley C, et al. Economic impact of palifermin on the costs of hospitalization for autologous hematopoietic stem-cell transplant: analysis of phase 3 trial results. Biol Blood Marrow Transplant. 2007;13:806-13. |
PMid:17580258 |
17. Chitapanarux I, Tungkasamit T, Petsuksiri J, Kannarunimit D, Katanyoo K, Chakkabat C, et al. Randomized control trial of benzydamine HCl versus sodium bicarbonate for prophylaxis of concurrent chemoradiation-induced oral mucositis. Support Care Cancer. 2018;26:879-86. |
PMid:28942587 |
18. Kanoh S, Rubin BK. Mechanisms of action and clinical application of macrolides as immunomodulatory medications. Clin Microbiol Rev. 2010;23:590-615. |
PMid:20610825 PMCid:PMC2901655 |
19. Hamoya T, Miyamoto S, Tomono S, Fujii G, Nakanishi R, Komiya M, et al. Chemopreventive effects of a low-side-effect antibiotic drug, erythromycin, on mouse intestinal tumors. J Clin Biochem Nutr. 2017;60:199-207. |
PMid:28584401 PMCid:PMC5453017 |
20. Zimmermann P, Ziesenitz VC, Curtis N, Ritz N. The Immunomodulatory Effects of Macrolides-A Systematic Review of the Underlying Mechanisms. Front Immunol. 2018;9:302. |
PMid:29593707 PMCid:PMC5859047 |
21. Iino Y, Toriyama M, Kudo K, Natori Y, Yuo A. Erythromycin inhibition of lipopolysaccharide-stimulated tumor necrosis factor alpha production by human monocytes in vitro. Ann Otol Rhinol Laryngol Suppl. 1992;157:16-20. |
PMid:1416647 |
22. Takizawa H, Desaki M, Ohtoshi T, Kikutani T, Okazaki H, Sato M, et al. Erythromycin suppresses interleukin 6 expression by human bronchial epithelial cells: a potential mechanism of its anti-inflammatory action. Biochem Biophys Res Commun. 1995;210:781-6. |
PMid:7763252 |
23. Chen B, Jiang L, Zhao W, Yu R, Hou XM. Ameliorating effect of erythromycin on bleomycin-induced pulmonary fibrosis: role of alveolar macrophage activation and cytokine release. Respirology. 1997;2:151-5. |
PMid:9441129 |
24. Aoki Y, Kao PN. Erythromycin inhibits transcriptional activation of NF-kappaB, but not NFAT, through calcineurin-independent signaling in T cells. Antimicrob Agents Chemother. 1999;43:2678-84. |
PMid:10543746 PMCid:PMC89542 |
25. Ianaro A, Ialenti A, Maffia P, Sautebin L, Rombolà L, Carnuccio R, et al. Anti-inflammatory activity of macrolide antibiotics. J Pharmacol Exp Ther. 2000;292:156-63. |
PMid:10604943 |
26. Abeyama K, Kawahara K, Iino S, Hamada T, Arimura S, Matsushita K, et al. Antibiotic cyclic AMP signaling by "primed" leukocytes confers anti-inflammatory cytoprotection. J Leukoc Biol. 2003;74:908-15. |
PMid:12960287 |
27. Desaki M, Okazaki H, Sunazuka T, Omura S, Yamamoto K, Takizawa H. Molecular mechanisms of anti-inflammatory action of erythromycin in human bronchial epithelial cells: possible role in the signaling pathway that regulates nuclear factor-kappaB activation. Antimicrob Agents Chemother. 2004;48:1581-5. |
PMid:15105108 PMCid:PMC400526 |
28. He Z, Li B, Yu L, Liu Q, Zhong N, Ran P. Suppression of oxidant-induced glutathione synthesis by erythromycin in human bronchial epithelial cells. Respiration. 2008;75:202-9. |
PMid:18032881 |
29. Bai J, Qiu SL, Zhong XN, Huang QP, He ZY, Zhang JQ, et al. Erythromycin enhances CD4+Foxp3+ regulatory T-cell responses in a rat model of smoke-induced lung inflammation. Mediators Inflamm. 2012;2012:410232. |
PMid:22701274 PMCid:PMC3371355 |
30. Zhou Y, Tan X, Kuang W, Liu L, Wan L. Erythromycin ameliorates cigarette-smoke-induced emphysema and inflammation in rats. Transl Res. 2012;159:464-72. |
PMid:22633097 |
31. Cai C, Qiu G, Gong X, Chen Y, Zhao H. Effects of erythromycin on γ-glutamyl cysteine synthetase and interleukin-1β in hyperoxia-exposed lung tissue of premature newborn rats. J Pediatr. 2014;90:493-9. |
PMid:24878007 |
32. Altenburg J, de Graaff CS, van der Werf TS, Boersma WG. Immunomodulatory effects of macrolide antibiotics - part 1: biological mechanisms. Respiration. 2011;81:67-74. |
PMid:20733281 |
33. Mitchell S, Vargas J, Hoffmann A. Signaling via the NFκB system. Wiley Interdiscip Rev Syst Biol Med. 2016;8:227-41. |
PMid:26990581 PMCid:PMC8363188 |
34. Sardaro N, Della Vella F, Incalza MA, DI Stasio D, Lucchese A, Contaldo M, et al. Oxidative Stress and Oral Mucosal Diseases: An Overview. In Vivo. 2019;33:289-96. |
PMid:30804105 PMCid:PMC6506298 |
35. Katayama Y, Inaba T, Nito C, Ueda M. Neuroprotective effects of erythromycin on ischemic injury following permanent focal cerebral ischemia in rats. Neurol Res. 2016;38:275-84. |
PMid:27078702 |
36. Morikawa T, Kadota JI, Kohno S, Kondo T. Superoxide dismutase in alveolar macrophages from patients with diffuse panbronchiolitis. Respiration. 2000;67:546-51. |
PMid:11070461 |
37. Schmidt E, Thoennissen NH, Rudat A, Bieker R, Schliemann C, Mesters RM, et al. Use of palifermin for the prevention of high-dose methotrexate-induced oral mucositis. Ann Oncol. 2008;19:1644-9. |
PMid:18453519 |
38. Lin HC, Wang CH, Liu CY, Yu CT, Kuo HP. Erythromycin inhibits beta2-integrins (CD11b/CD18) expression, interleukin-8 release and intracellular oxidative metabolism in neutrophils. Respir Med. 2000;94:654-60. |
PMid:10926336 |
39. Labro MT. Macrolide antibiotics: current and future uses. Expert Opin Pharmacother. 2004;5:541-50. |
PMid:15013923 |
40. Wu L, Lin JH, Bao K, Li PF, Zhang WG. In vitro effects of erythromycin on RANKL and nuclear factor-kappa B by human TNF-alpha stimulated Jurkat cells. Int Immunopharmacol. 2009;9:1105-9. |
PMid:19500694 |